These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28913946)

  • 1. Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met.
    Carrà G; Nicolini G; Lax A; Bartoli F; Castellano F; Chiorazzi A; Gamba G; Bava M; Crocamo C; Papagno C
    Hum Psychopharmacol; 2017 Nov; 32(6):. PubMed ID: 28913946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders.
    Carrà G; Nicolini G; Crocamo C; Lax A; Amidani F; Bartoli F; Castellano F; Chiorazzi A; Gamba G; Papagno C; Clerici M
    Nord J Psychiatry; 2017 Jul; 71(5):332-339. PubMed ID: 28635556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.
    Huang E; Zai CC; Lisoway A; Maciukiewicz M; Felsky D; Tiwari AK; Bishop JR; Ikeda M; Molero P; Ortuno F; Porcelli S; Samochowiec J; Mierzejewski P; Gao S; Crespo-Facorro B; Pelayo-Terán JM; Kaur H; Kukreti R; Meltzer HY; Lieberman JA; Potkin SG; Müller DJ; Kennedy JL
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26745992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
    Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
    Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The catechol O-methyltransferase Val158Met polymorphism is not associated with broad-based cognitive functioning in schizophrenia.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Sullens A; Yolken RH
    Schizophr Res; 2007 Nov; 96(1-3):87-92. PubMed ID: 17601704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Single Nucleotide Polymorphisms in Catechol-O-Methyltransferase and Serine-Threonine Protein Kinase Genes in the Pakistani Schizophrenic Population: A Study with Special Emphasis on Cannabis and Smokeless Tobacco.
    Nawaz R; Siddiqui S
    CNS Neurol Disord Drug Targets; 2015; 14(8):1086-95. PubMed ID: 25801838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction Between Val158Met Catechol-O-Methyltransferase Polymorphism and Social Cognitive Functioning in Schizophrenia: Pilot Study.
    Tylec A; Jeleniewicz W; Mortimer A; Bednarska-Makaruk M; Kucharska K
    Ann Hum Genet; 2017 Nov; 81(6):267-275. PubMed ID: 28856668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
    Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
    J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perception of emotion in facial stimuli: The interaction of ADRA2A and COMT genotypes, and sex.
    Tamm G; Kreegipuu K; Harro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():87-95. PubMed ID: 26234518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population.
    Kim YR; Kim JH; Kim SJ; Lee D; Min SK
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):820-5. PubMed ID: 18789857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.
    Ohnishi T; Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Iida H; Noguchi H; Nakabayashi T; Hori H; Ohmori M; Tsukue R; Anami K; Hirabayashi N; Harada S; Arima K; Saitoh O; Kunugi H
    Brain; 2006 Feb; 129(Pt 2):399-410. PubMed ID: 16330500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperament and character in remitted and symptomatic patients with schizophrenia: modulation by the COMT Val158Met genotype.
    Hori H; Fujii T; Yamamoto N; Teraishi T; Ota M; Matsuo J; Kinoshita Y; Ishida I; Hattori K; Okazaki M; Arima K; Kunugi H
    J Psychiatr Res; 2014 Sep; 56():82-9. PubMed ID: 24888672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia, cannabis use and Catechol-O-Methyltransferase (COMT): Modeling the interplay on cognition.
    Bosia M; Buonocore M; Bechi M; Stere LM; Silvestri MP; Inguscio E; Spangaro M; Cocchi F; Bianchi L; Guglielmino C; Cavallaro R
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():363-368. PubMed ID: 30790675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
    Shukla AA; Jha M; Birchfield T; Mukherjee S; Gleason K; Abdisalaam S; Asaithamby A; Adams-Huet B; Tamminga CA; Ghose S
    Schizophr Res; 2016 May; 173(1-2):94-100. PubMed ID: 27021555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis.
    Mata I; Perez-Iglesias R; Pelayo-Teran JM; Rodríguez-Sanchez JM; Gonzalez-Blanch C; Carrasco-Marin E; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2008 Jul; 102(1-3):206-9. PubMed ID: 18407467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of COMT genotype on aggressive behaviour in a community cohort of schizophrenic patients.
    Tosato S; Bonetto C; Di Forti M; Collier D; Cristofalo D; Bertani M; Zanoni M; Marrella G; Lazzarotto L; Lasalvia A; De Gironcoli M; Tansella M; Dazzan P; Murray R; Ruggeri M
    Neurosci Lett; 2011 May; 495(1):17-21. PubMed ID: 21402125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment.
    Galderisi S; Maj M; Kirkpatrick B; Piccardi P; Mucci A; Invernizzi G; Rossi A; Pini S; Vita A; Cassano P; Stratta P; Severino G; Del Zompo M
    Neuropsychobiology; 2005; 52(2):83-9. PubMed ID: 16037677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.
    Goldberg TE; Egan MF; Gscheidle T; Coppola R; Weickert T; Kolachana BS; Goldman D; Weinberger DR
    Arch Gen Psychiatry; 2003 Sep; 60(9):889-96. PubMed ID: 12963670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COMT genotype and response to cognitive remediation in schizophrenia.
    Lindenmayer JP; Khan A; Lachman H; McGurk SR; Goldring A; Thanju A; Kaushik S
    Schizophr Res; 2015 Oct; 168(1-2):279-84. PubMed ID: 26255563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMT Met (158) modulates facial emotion recognition in bipolar I disorder mood episodes.
    Soeiro-de-Souza MG; Bio DS; David DP; Rodrigues dos Santos D; Kerr DS; Gattaz WF; Machado-Vieira R; Moreno RA
    J Affect Disord; 2012 Feb; 136(3):370-6. PubMed ID: 22222175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.